Helius Medical Technologies (NASDAQ:HSDT) Given Hold Rating at Maxim Group

Maxim Group reiterated their hold rating on shares of Helius Medical Technologies (NASDAQ:HSDT) in a report released on Wednesday, Benzinga reports.

Helius Medical Technologies Stock Performance

Shares of Helius Medical Technologies stock opened at $0.55 on Wednesday. Helius Medical Technologies has a one year low of $0.37 and a one year high of $9.50. The company has a market capitalization of $1.63 million, a PE ratio of -0.04 and a beta of 1.60. The company has a 50-day simple moving average of $0.70 and a two-hundred day simple moving average of $1.67.

Helius Medical Technologies (NASDAQ:HSDT) last released its quarterly earnings results on Monday, August 12th. The company reported ($0.64) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.50) by ($0.14). Helius Medical Technologies had a negative return on equity of 258.06% and a negative net margin of 1,487.54%. The firm had revenue of $0.18 million during the quarter. During the same quarter in the prior year, the company earned ($3.00) earnings per share.

Hedge Funds Weigh In On Helius Medical Technologies

A hedge fund recently bought a new stake in Helius Medical Technologies stock. Armistice Capital LLC bought a new stake in Helius Medical Technologies, Inc. (NASDAQ:HSDT) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 130,000 shares of the company’s stock, valued at approximately $127,000. Armistice Capital LLC owned 4.39% of Helius Medical Technologies at the end of the most recent reporting period. Hedge funds and other institutional investors own 18.63% of the company’s stock.

About Helius Medical Technologies

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.